- Report
- October 2024
- 191 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- April 2025
- 50 Pages
Global
From €2512EUR$2,650USD£2,098GBP
Azelnidipine is a calcium channel blocker used to treat hypertension and angina pectoris. It is a dihydropyridine derivative and is classified as a third-generation calcium channel blocker. It is used to reduce blood pressure and improve blood flow to the heart. It works by blocking the entry of calcium into the cells of the heart and blood vessels, which helps to relax the blood vessels and reduce blood pressure.
Azelnidipine is available in both oral and intravenous formulations. It is marketed under various brand names, including Azelnidipine, Azelnidipine-H, Azelnidipine-L, and Azelnidipine-XL. It is available in various strengths and formulations, including tablets, capsules, and oral solutions.
Azelnidipine is used in combination with other drugs to treat hypertension and angina pectoris. It is also used to reduce the risk of stroke and heart attack in patients with coronary artery disease.
The azelnidipine market is highly competitive, with several major players operating in the space. Some of the key players in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more